Loading...
XJSEAIP
Market cap569mUSD
Dec 20, Last price  
6,502.00ZAR
1D
-0.90%
1Q
-3.66%
Jan 2017
34.76%
IPO
87.38%
Name

Adcock Ingram Holdings Ltd

Chart & Performance

D1W1MN
XJSE:AIP chart
P/E
1,282.01
P/S
108.22
EPS
5.07
Div Yield, %
0.04%
Shrs. gr., 5y
-1.44%
Rev. gr., 5y
6.38%
Revenues
9.64b
+5.60%
3,317,525,0003,831,524,0002,879,200,0003,531,467,0004,115,265,0004,440,654,0004,453,567,0004,599,249,0005,445,639,0004,949,917,0005,528,369,0005,545,610,0005,936,056,0006,540,255,0007,078,438,0007,346,558,0007,776,854,0008,705,817,0009,131,852,0009,643,128,000
Net income
814m
-9.39%
769,088,000789,129,000570,400,000324,734,000789,882,000643,228,000764,800,000705,641,000587,844,000-914,149,500197,932,000168,801,000553,534,000637,943,000687,986,000676,366,000657,463,000800,345,000898,410,000814,009,000
CFO
944m
+147.24%
412,110,000625,832,000709,082,000207,378,000753,687,000862,100,000526,382,000457,661,000-28,289,000102,453,500427,486,000522,121,000455,433,000382,926,000505,963,000525,880,000329,339,000657,333,000381,752,000943,828,000
Dividend
Sep 18, 2024150 ZAR/sh
Earnings
Feb 19, 2025

Profile

Adcock Ingram Holdings Limited manufactures, markets, and distributes healthcare products in South Africa, the United States, Canada, the United Kingdom, rest of Europe, and internationally. It offers a portfolio of over-the-counter products, prescription medicines, and consumer products, as well as instrumentation and surgical products. The company also provides a range of pharmaceutical products, such as women's health, cannabidiol oil, antiretroviral, dermatology, central nervous system, respiratory, ophthalmology, generics, cardiovascular, pain, gastroenterology, energy supplements, colds and flu, personal care, feminine hygiene, digestive well-being, allergies, baby care, cough, food and nutrition supplements, vitamins, and minerals supplements. In addition, it manufactures and supplies hospital and critical care products, including intravenous solutions, renal dialysis systems, and blood collection products. The company serves private and public sectors. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa.
IPO date
Aug 25, 2008
Employees
Domiciled in
ZA
Incorporated in
ZA

Valuation

Title
ZAR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
9,643,128
5.60%
9,131,852
4.89%
8,705,817
11.95%
Cost of revenue
7,478,970
6,859,844
6,541,445
Unusual Expense (Income)
NOPBT
2,164,158
2,272,008
2,164,372
NOPBT Margin
22.44%
24.88%
24.86%
Operating Taxes
310,812
307,222
301,265
Tax Rate
14.36%
13.52%
13.92%
NOPAT
1,853,346
1,964,786
1,863,107
Net income
814,009
-9.39%
898,410
12.25%
800,345
21.73%
Dividends
(379,022)
(375,368)
(313,811)
Dividend yield
Proceeds from repurchase of equity
(395,511)
(475,212)
(9,765)
BB yield
Debt
Debt current
42,460
45,062
27,717
Long-term debt
518,620
595,381
647,765
Deferred revenue
Other long-term liabilities
12,527
13,081
14,079
Net debt
(204,954)
(142,521)
(224,070)
Cash flow
Cash from operating activities
943,828
381,752
657,333
CAPEX
(127,741)
(148,086)
(329,783)
Cash from investing activities
(125,137)
(141,624)
(323,311)
Cash from financing activities
(810,431)
(504,638)
(37,494)
FCF
1,736,312
3,468,912
(11,209)
Balance
Cash
89,417
91,540
345,485
Long term investments
676,617
691,424
554,067
Excess cash
283,878
326,371
464,261
Stockholders' equity
5,944,665
5,592,497
4,989,929
Invested Capital
5,421,965
5,338,120
5,091,449
ROIC
34.45%
37.68%
37.81%
ROCE
36.89%
39.09%
38.04%
EV
Common stock shares outstanding
154,633
163,754
164,770
Price
Market cap
EV
EBITDA
2,364,772
2,470,042
2,357,029
EV/EBITDA
Interest
97,462
59,664
45,401
Interest/NOPBT
4.50%
2.63%
2.10%